Skip to content

Evaluation of the effect of remote ischemic preconditioning on improving sleep quality in patients with sleep disorders

Evaluation of the effect of remote ischemic preconditioning on improving sleep quality in patients with sleep disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400091561
Enrollment
Unknown
Registered
2024-10-30
Start date
2024-10-31
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep disorder

Interventions

CON:Based on various classifications of sleep disorders, the subjects were categorized into three groups: occupational insomnia, age-related insomnia, and pathological insomnia. These groups were then
RIC:Based on various sleep disorder classifications, participants were categorized into three groups: occupational insomnia, senile insomnia, and pathological insomnia. Additionally, the intervention

Sponsors

North China University of Science and Technology Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 85 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: (1) 25-85 years old, gender unlimited; (2) There is sleep deprivation, pittsburgh sleep quality index (PSQI) >5 points. (3) Voluntarily participate in the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: Exclusion criteria: (1) RIC contraindicated patients, including patients with vasculitis, leg vein thrombosis, hypertension, systolic blood pressure >180mmHg, and new external injuries in the extremities; (2) Those with moderate anxiety and depression, HRDS-17>17 points or HAMA>14 points; (3) any previous history of other mental illness, including substance abuse or dependence; (4) Patients with organic lesions in sleep disorders that meet surgical indications; (5) Those who could not complete the scale assessment, blood sample collection, or could not complete the study. RIC use contraindications exclusion criteria: (1) suffering from erysipelas; (2) suffering from pulmonary edema; (3) suffering from malignant tumors; (4) infants and pregnant women; (5) suffered from thrombotic superficial phlebitis; (6) suffering from acute inflammatory skin diseases; (7) Acute venous thrombosis; (8) Severe limb necrosis and infected persons; (9) Have an uncontrolled infection and unexplained fever; (10) Systolic blood pressure =180mmHg, diastolic blood pressure =110mmHg; (11) Peripheral vascular disease (diabetes caused by more serious vascular damage); (12) suffering from coagulation dysfunction (hemophilia, leukemia) or active visceral bleeding; (13) Patients with severe diseases of the brain, lung, liver, kidney and other organs (acute, critical, serious patients) are not controlled and stable.

Design outcomes

Primary

MeasureTime frame
Pittsburgh Sleep Quality Index;Adenosine;5-hydroxytryptamine;

Secondary

MeasureTime frame
Epworth sleepiness Scale;Melatonin;

Countries

China

Contacts

Public ContactLiangdan Sun

North China University of Science and Technology Affiliated Hospital

ahmusld@163.com+86 315 881 6234

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026